Immunotherapy Drug Wins Key Lung Cancer OK – Newsmax
Newsmax |
Immunotherapy Drug Wins Key Lung Cancer OK
Newsmax AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors. The U.S. Food and Drug Administration said … |
